期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

左西孟坦治疗失代偿性心力衰竭的临床观察 被引量：5

原文传递
导出
摘要 国内外多项前瞻性临床研究[1-4]证实，左西孟坦能较传统静脉治疗药物短期内迅速改善急性失代偿性心力衰竭（DHF）患者的血流动力学状况，成为现代心力衰竭（心衰）治疗的一种新药。为了探讨其治疗的有效性及安全性，笔者采用左西孟坦治疗DHF患者23例，并与常规治疗相比较。
作者 薛歆 孟晓萍 常静
机构地区 吉林大学第二医院心血管内科 检验科
出处 《中国基层医药》 CAS 2011年第19期2702-2703,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 急性失代偿性心力衰竭 治疗药物 左西孟坦 临床观察 前瞻性临床研究 血流动力学 常规治疗 国内外
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

  • 1王雷,崔亮,魏嘉平,李广平,齐国先,郝玉明,王文志,李慧敏,刘俊,姜东炬,张玉东.静脉注射左西孟旦治疗重度失代偿性心力衰竭患者的疗效分析[J].中华心血管病杂志,2010,38(6):527-530. 被引量：58
  • 2Biala A,Martonen E,Kaheinen P,et al. Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure. Hypertens Res,2010,33(10) :1004-1011.
  • 3Parissis JT,Rafouli-Stergiou P,Stasinos V,et al. Inotropes in cardiac patients :update 2011. Curr Opin Crit Care,2010,16(5) :432-441.
  • 4Yontar OC ,Yilmaz MB ,Yalta K,et al. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter. Anadolu Kardiyol Derg,2010,10(4) :310-316.

二级参考文献10

  • 1Nieminen MS,Bohm M,Cowie MR,et al.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure:the Task Force on Acute Heart Failure of the European Society of Cardiology.Eur Heart J,2005,26:384-416.
  • 2Follath F,Cleland JG,Just H,et al.Efficacy and safety of intravenous levosimendan compared with dubutamine in severe lowoutput heart failure (the LIDO study):a randomised donble-blind trial.Lancet,2002,360:196-202.
  • 3Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer,levosimendan,in patients with left ventricular failure due to an acute myocardial infarction.A randomized,placebo-controlled,double-blind study (RUSSIAN).Eur Heart J,2002,23:1422-1432.
  • 4Cleland JG,Ghosh J,Freemantle N,et al.Clinical trials update and cumulative meta-analyses from the American College of Cardiology:WATCH,SCD-HeFT,DINAMIT,CASINO,INSPIRE,STRATUS-US,RlO-Lipids and cardiac resynchronisation therapy in heart failure.Eur J Heart Fail,2004,6:501-508.
  • 5McMurray JJ,Pfeffer MA.Heart failure.Lancet,2005,365:1877-1889.
  • 6Lloyd-Jones DM,Larsen MG,Leip EP,et al.Lifetime risk for developing congestive heart failure:the Framingham Heart Study.Circulation,2002,106:3068-3072.
  • 7Sharma M,Tserlink JR.A rational approach for the treatment of acute heart failure:current strategies and future options.Curr Opin Cardiol,2004,19:254-263.
  • 8Dec GW.Acute decompensated heart failure:the shrinking role of inotropic therapy.J Am Coil Cardiol,2005,46:65-67.
  • 9Nieminen MS,Akkila J,Hasenfuss G,et al.Hemodynamic and neurohumoral effects of continuous infusion of levesimendan in patients with congestive heart failure.J Am Coll Cardiol,2000,36:1903-1912.
  • 10Nijhawan N,Nicolosi AC,Montgomery MW,et al.Levosimendan enhances cardia performance after cardiopulmonary bypass:a prospective,randomized placebo-controlled trial.J Cardiovasc Pharmacol,1999,34:219-228.

共引文献57

同被引文献31

  • 1耿婕,陈庆良,刘艳霞.左西孟旦对心肌保护作用的研究进展[J].天津医药,2007,35(7):558-560. 被引量：1
  • 2Perrone SV, Kaplinsky EJ. Calcium sensitizer agents:a new class of inotropic agents in the treatment of decompensated heart fail- ure. Int J Cardio1,2005,103 ( 3 ) :248-255.
  • 3Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for de- veloping congestive heart failure:the Framingham Heart Study. Circulation, 2002,106 ( 24 ) : 3068.
  • 4McMurray JJ, Pfeifer MA. Heart failure. Lancet,2005,365 (9474) : 1877-1889.
  • 5Dec GW. Acute deeompensated heart failure:the shrinking role of inotropic therapy. J Am Co 11 Cardiol,2005,46( 1 ) :65-67.
  • 6Gheorghiade M,Teerlink JR, Mebazaa A. Pharmacology of New A- gents for Acute Heart Failure Syndromes. Am J Cardiol,2005,96 (6) :68-73.
  • 7Kivikko M, Lehtonen L. Levosimendan:a new inodilatory drug for the treatment of decopen sated heart failure. Curr Pharm Des, 2005,11 (4) :435-455.
  • 8Rognoni A, Lupi A, Lazzero M, et al.Levosimendan: frOm basic science to clinical trials[J].Recent Pat cardiovrnc Durg Discov, 2011, 6(1): 9-15.
  • 9Nieminen M S, Bohm M, Cowie M R, et al.Executive summary of theguid elines on the diagnosis and treatment of acute heart failure : the task force on acute heart failure of the european society of cardiology[J].Eur Heart J, 2005, 26(5): 384-416.
  • 10Pasqui A L, Mallei S, Di Renzo M, et al.Levosimendan improves pro/ anti - inflammatory cytokines imbalance in male patients with advanced heart failure. A randomized, double-blind, placebo-controlled study[J].Int JCardiol, 2011, 147(2): 314-315.

引证文献5

二级引证文献18

中国基层医药
2011年 第19期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部